Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 1057-1062

  Thapa, Raba ^a   Maharjan, Nhukesh ^a   Paudyal, Govinda ^a  

^a TILGANGA INSTITUTE OF OPHTHALMOLOGY   (Nepal)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Macular edema

Indexed keywords

BEVACIZUMAB; CYCLOPLEGIC AGENT; STEROID;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA EDEMA; SYSTEMIC DISEASE; THROMBOEMBOLISM; TREATMENT DURATION; UVEITIS; VISUAL ACUITY;

EID: 84865662087     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S30555     Document Type: Article

References (16)

1. Thapa R, Paudyal G, Bernstein PS. Demographic characteristics, patterns, and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study. Clinic Experiment Ophthalmol. 2010;38(6):583-590.
2. Lim LL, Cheung N, Wang JJ, et al. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol. 2008;92(10):1316-1319.
3. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2009:98;133-141.
4. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984: 98(3):271-282.
5. Hou J, Tao Y, Jiang YR, Li XX, Gao L. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study. Chin Med J (Engl). 2009;122(22): 2695-2699.
6. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004;122(8):1131-1136.
7. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):309-315.
8. Rosenfeld PH, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36(4):336-339.
9. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27(4): 419-425.
10. Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol. 2009;93(4):452-456.
11. Demir M, Oba E, Gulkilik G, Odabasi M, Ozdal E. Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Clin Ophthalmol. 2011;5:745-749.
12. Ahmadi AA, Chuo JY, Banashkevich A, Ma PE, Maberley DA. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion. Can J Ophthalmol. 2009; 44(2):154-159.
13. Gutièrrez JC, Barquet LA, Caminal JM, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion. Clin Ophthalmol. 2008;2(4):787-791.
14. Abegg M, Tappeiner C, Wolf-Schnurrbusch U, Barthelmes D, Wolf S, Fleischhauer J. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol. 2008;8:18.
15. Figueroa MS, Contreras I, Noval CS, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol. 2010;94(8):1052-1056.
16. Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol. 2008;92(4):518-522.